Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008
Top Cited Papers
Open Access
- 20 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (2) , 144-149
- https://doi.org/10.1093/cid/cir308
Abstract
Background. In the past decade, new methicillin-resistant Staphylococcus aureus (MRSA) strains have emerged as a predominant cause of community-associated skin and soft-tissue infections (SSTIs). Little information exists regarding trends in MRSA prevalence and molecular characteristics or regarding antimicrobial susceptibility profiles of S. aureus isolates. Methods. We enrolled adults with acute, purulent SSTIs presenting to a US network of 12 emergency departments during August 2008. Cultures and clinical information were collected. S. aureus isolates were characterized by antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and toxin genes detection. The prevalence of S. aureus and MRSA and isolate genetic characteristics and susceptibilities were compared with those from a similar study conducted in August 2004. Results. The prevalence of MRSA was 59% among all SSTIs during both study periods; however, the prevalence by site varied less in 2008 (38%–84%), compared with 2004 (15%–74%). Pulsed-field type USA300 continued to account for almost all MRSA isolates (98%). Susceptibility to trimethoprim-sulfamethoxazole, clindamycin, and tetracycline among MRSA isolates remained greater than 90% in 2008. A higher proportion of MRSA infections were treated with an agent to which the infecting isolate was susceptible in vitro in 2008 (97%), compared with 2004 (57%). Conclusions. Similar to 2004, MRSA remained the most common identifiable cause of purulent SSTIs among patients presenting to a network of US emergency departments in 2008. The infecting MRSA isolates continued to be predominantly pulsed-field type USA300 and susceptible to recommended non–β-lactam oral agents. Clinician prescribing practices have shifted from MRSA-inactive to MRSA-active empirical antimicrobial regimens.Keywords
This publication has 20 references indexed in Scilit:
- Randomized Controlled Trial of Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscesses in Patients at Risk for Community-Associated Methicillin-Resistant Staphylococcus aureus InfectionAnnals of Emergency Medicine, 2010
- Randomized, Controlled Trial of Antibiotics in the Management of Community-Acquired Skin Abscesses in the Pediatric PatientAnnals of Emergency Medicine, 2010
- Changing Incidence of Methicillin-Resistant Staphylococcus aureus Skin Abscesses in a Pediatric Emergency DepartmentPediatric Emergency Care, 2009
- Risk Factors for Methicillin-Resistant Staphylococcal aureus Skin and Soft Tissue Infections Presenting in Primary Care: A South Texas Ambulatory Research Network (STARNet) StudyThe Journal of the American Board of Family Medicine, 2009
- Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus InfectionAntimicrobial Agents and Chemotherapy, 2007
- Prevalence and demographics of methicillin resistant Staphylococcus aureusin culturable skin and soft tissue infections in an urban emergency departmentBMC Emergency Medicine, 2007
- Cutaneous Community‐associated Methicillin‐resistant Staphylococcus aureus among All Skin and Soft‐tissue Infections in Two Geographically Distant Pediatric Emergency DepartmentsAcademic Emergency Medicine, 2007
- Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adultsCurrent Medical Research and Opinion, 2006
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue InfectionsAnnals of Emergency Medicine, 2005